Clinical Trial: A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196722) titled 'A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease' on Sept. 22.

Brief Summary: The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

Study Start Date: Oct. 23

Study Type: INTERVENTIONAL

Condition: Crohn Disease

Intervention: DRUG: Icotrokinra

Icotrokinra will be administered orally, daily.

DRUG: Placebo

Matching placebo will be administered orally, daily.

Recruitment Status: N...